Zeynep Eroglu
City Of Hope National Medical Center(US)Moffitt Cancer Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Melanoma and MAPK Pathways, Immunotherapy and Immune Responses, Cutaneous Melanoma Detection and Management
Most-Cited Works
- → Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors(2018)2,518 cited
- → Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab(2016)814 cited
- → RETRACTED ARTICLE: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance(2016)390 cited
- → Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma(2017)386 cited
- → Clinical outcomes in metastatic uveal melanoma treated with PD‐1 and PD‐L1 antibodies(2016)367 cited
- → Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations(2018)355 cited
- → High response rate to PD-1 blockade in desmoplastic melanomas(2018)329 cited
- → Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms(2015)328 cited
- → Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy(2015)309 cited
- → The efficacy of anti‐PD‐1 agents in acral and mucosal melanoma(2016)298 cited